Cytokinetics Inc (NASDAQ:CYTK)

8.40
Delayed Data
As of Jun 22
 +0.20 / +2.44%
Today’s Change
6.75
Today|||52-Week Range
15.95
+3.07%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.20
Today’s open8.30
Day’s range8.05 - 8.60
Volume969,977
Average volume (3 months)365,665
Market cap$506.8M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-764.10%
Earnings growth (this year)+26.83%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-87.44%
P/E ratioNM
Price/Sales30.12
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.15+0.79%
FLXNFlexion Therapeutics...+0.48+1.77%
ACRSAclaris Therapeutics...-0.53-2.66%
AKBAAkebia Therapeutics ...-0.09-0.83%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.4M
Annual profit (last year)-$127.8M
Net profit margin-955.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts